Quantum Pharma PLC Notification of Major Interest in Shares (1382P)
November 14 2016 - 10:20AM
UK Regulatory
TIDMQP.
RNS Number : 1382P
Quantum Pharma PLC
14 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer QUANTUM PHARMA PLC
or the underlying issuer
of existing shares to which
voting rights are attached:
----------------------------- -------------------
2 Reason for the notification (please tick the
appropriate box or boxes):
----------------------------------------------------
An acquisition or disposal of voting rights Yes
---------------------------------------------- ----
An acquisition or disposal of qualifying
financial instruments which may result in
the acquisition of shares already issued
to which voting rights are attached
---------------------------------------------- ----
An acquisition or disposal of instruments
with similar economic effect to qualifying
financial instruments
---------------------------------------------- ----
An event changing the breakdown of voting
rights
---------------------------------------------- ----
Other (please
specify):
-------------------------------------------- ----
3. Full name of person(s)
subject to the notification Harwood Capital LLP
obligation: (as investment adviser/manager)
and North Atlantic
Smaller Companies Investment
Trust plc
--------------------------------- ----------------------------------
4. Full name of shareholder(s)
(if different from 3.): 1. North Atlantic Smaller
Companies Investment
Trust PLC
2. Oryx International
Growth Fund Limited
--------------------------------- ----------------------------------
5. Date of the transaction 11 NOVEMBER 2016
and date on which the threshold
is crossed or reached:
--------------------------------- ----------------------------------
6. Date on which issuer 14 NOVEMBER 2016
notified:
--------------------------------- ----------------------------------
7. Threshold(s) that is/are
crossed or
reached: ABOVE 14%
--------------------------------- ----------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
----------------------------------------------------------------------------------------------------------
Class/type Situation Resulting situation after
of previous the triggering transaction
shares to the triggering
transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------- ------------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights
Shares Voting shares rights
Rights
-------------- ------------- ------------- ------------- ------------------------ -------------------
Direct Direct Indirect Direct Indirect
-------------- ------------- ------------- ------------- ------------- --------- -------- ---------
Holder
1:
3,921,158 3,921,158 10,000,000 10,000,000 5.91%
Holder
2: 10,000,000 10,000,000 15,000,000 15,000,000 8.87%
-------------- ------------- ------------- ------------- ------------- --------- -------- ---------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of % of voting
instrument date Conversion voting rights
Period rights that
may be
acquired
if the
instrument
is
exercised/
converted.
------------------ ----------- ------------ ------------- ------------
C: Financial Instruments with similar economic
effect to Qualifying Financial Instruments
----------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of % of voting
financial price date Conversion voting rights
instrument period rights
instrument
refers
to
------------ --------- ----------- ------------ ------------ ----------------
Nominal Delta
------------ --------- ----------- ------------ ------------ -------- ------
Total (A+B+C)
-----------------------------------------------
Number of voting rights Percentage of voting
rights
------------------------ ---------------------
25,000,000 14.78%
------------------------ ---------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
------------------------------------------------------------
Proxy Voting:
--------------------------------
10. Name of the proxy holder:
------------------------------
11. Number of voting rights
proxy holder will cease
to hold:
------------------------------
12. Date on which proxy
holder will cease to hold
voting rights:
------------------------------
13. Additional information:
------------------------------- --------------
14. Contact name: Jane Muir
------------------------------- --------------
15. Contact telephone number: 020 8819 6486
------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGAGGUPQGQC
(END) Dow Jones Newswires
November 14, 2016 11:20 ET (16:20 GMT)
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From Apr 2024 to May 2024
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Quantum Phar. (London Stock Exchange): 0 recent articles
More Quantum Phar. News Articles